Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma

Cancer Epidemiology

Volumn 33, Issue 3-4, 2009, Pages 276-280

  Gold, Laura S ^a,b   De Roos, Anneclaire J ^a,b   Brown, Elizabeth E ^c   Lan, Qing ^d   Milliken, Kevin ^a,b   Davis, Scott ^a,b   Chanock, Stephen J ^d   Zhang, Yawei ^e   Severson, Richard ^f   Zahm, Sheila H ^d   Zheng, Tongzhang ^e   Rothman, Nat ^d   Baris, Dalsu ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e YALE UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arylhydrocarbon hydroxylase receptor (AHR); Cytochrome P450 enzymes (CYP1B1, CYP2C9); Epoxide hydrolase (EPHX1); Multiple myeloma; NAD (P) H: quinone oxidoreductase (NQO1); Paraoxonase 1 (PON1)

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLHYDROCARBON HYDROXYLASE RECEPTOR; CYTOCHROME P450 1B1; CYTOCHROME P450 2C9; DIOXIN; EPOXIDE HYDROLASE; POLYCYCLIC AROMATIC HYDROCARBON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; ENZYME MECHANISM; FEMALE; GENE FUNCTION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIPLE MYELOMA; OXIDATION; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DIOXINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OXIDATION-REDUCTION; POLYCYCLIC HYDROCARBONS, AROMATIC; RISK FACTORS;

EID: 70349757186     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.08.005     Document Type: Article

References (58)

1. Altieri A., Chen B., Bermejo J.L., Castro F., and Hemminki K. Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer 42 (2006) 1661-1670
2. Lynch H.T., Sanger W.G., Pirruccello S., Quinn-Laquer B., and Weisenburger D.D. Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 93 (2001) 1479-1483
3. Mccrea A.P., and Morris T.C. Concurrent familial myeloma in northern Ireland. Cancer 58 (1986) 394-396
4. De Roos A.J., Baris D., Weiss N.S., and Herrinton L. Epidemiology of multiple myeloma. In: Malpas J.S., Bergsagel D., Kyle R.A., and Anderson D.C. (Eds). Multiple myeloma (2004), Philadelphia, PA, Elsevier, Inc.
5. Mester B., Nieters A., Deeg E., Elsner G., Becker N., and Seidler A. Occupation and malignant lymphoma: a population based case control study in Germany. Occup Environ Med 63 (2006) 17-26
6. Boffetta P., Stellman S.d., and Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 43 (1989) 554-559
7. Pearce N.E., Smith A.H., Howard J.K., Sheppard R.A., Giles H.J., and Teague C.A. Case-control study of multiple myeloma and farming. Br J Cancer 54 (1986) 493-500
8. Blair A., Sandler D., Thomas K., Hoppin J.A., Kamel F., Coble J., et al. Disease and injury among participants in the agricultural health study. J Agric Saf Health 11 (2005) 141-150
9. Brown L.M., Burmeister L.F., Everett G.D., and Blair A. Pesticide exposures and multiple myeloma in Iowa men. Cancer Causes Control 4 (1993) 153-156
10. Viel J., and Richardson S. Lymphoma, multiple myeloma and leukaemia among French Farmers in relation to pesticide exposure. Soc Sci Med 37 (1993) 771-777
11. 'T Mannetje A., Mclean D., Cheng S., Boffetta P., Colin D., and Pearce N. Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med 62 (2005) 34-40
12. Lee W.J., Hoppin J.A., Blair A., Lubin J.H., Dosemeci M., Sandler D.P., et al. Cancer incidence among pesticide applicators exposed to alachlor in the agricultural health study. Am J Epidemiol 159 (2004) 373-380
13. Nanni O., Falcini F., Buiatti E., Bucchi L., Naldoni M., Serra P., et al. Multiple myeloma and work in agriculture: results of a case-control study in Forli, Italy. Cancer Causes Control 9 (1998) 277-283
14. Kristensen P., Andersen A., Irgens L.M., Laake P., and Bye A.S. Incidence and risk factors of cancer among men and women in Norwegian agriculture. Scand J Work Environ Health 22 (1996) 14-26
15. Morris P.D., Koepsell T.D., Daling J.R., Taylor J.W., Lyon J.L., Swanson G.M., et al. Toxic substance exposure and multiple myeloma: a case-control study. J Natl Cancer Inst 76 (1986) 987-994
16. Swaen G.M., Van V.C., Slangen J.J., and Sturmans F. Cancer mortality among licensed herbicide applicators. Scand J Work Environ Health 18 (1992) 201-204
17. Baris D., Silverman D.T., Brown L.M., Swanson G.M., Hayes R.B., Schwartz A.G., et al. Occupation, pesticide exposure and risk of multiple myeloma. Scand J Work Environ Health 30 (2004) 215-222
18. De Roos A.J., Blair A., Rusiecki J.A., Hoppin J.A., Svec M., Dosemeci M., et al. Cancer incidence among glyphosate-exposed pesticide applicators in the agricultural health study. Environ Health Perspect 113 (2005) 49-54
19. Rusiecki J.A., De R.A., Lee W.J., Dosemeci M., Lubin J.H., Hoppin J.A., et al. Cancer incidence among pesticide applicators exposed to atrazine in the agricultural health study. J Natl Cancer Inst 96 (2004) 1375-1382
20. Mills P.K., Yang R., and Riordan D. Lymphohematopoietic cancers in the United Farm Workers of America (UFW), 1988-2001. Cancer Causes Control 16 (2005) 823-830
21. Pahwa P., McDuffie H.H., Dosman J.A., Robson D., Mclaughlin J.R., Spinelli J.J., et al. Exposure To animals and selected risk factors among Canadian farm residents with Hodgkin's disease, multiple myeloma, or soft tissue sarcoma. J Occup Environ Med 45 (2003) 857-868
22. Cocco P., Kazerouni N., and Zahm S.H. Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect 108 (2000) 1-4
23. Costantini A.S., Miligi L., and Vineis P. [An Italian multicenter case-control study on malignant neoplasms of the hematolymphopoietic system. hypothesis and preliminary results on work-related risks. Will (Working Group On Hematolymphopoietic Malignancies In Italy)]. Med Lav 89 (1998) 164-176
24. Blair A., Hartge P., Stewart P.A., McAdams M., and Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med 55 (1998) 161-171
25. Bethwaite P.B., Pearce N., and Fraser J. Cancer risks in painters: study based on the New Zealand cancer registry. Br J Ind Med 47 (1990) 742-746
26. Collins J.J., Ireland B., Buckley C.F., and Shepperly D. Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med 60 (2003) 676-679
27. Lundberg I., and Milatou-Smith R. Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. Scand J Work Environ Health 24 (1998) 270-275
28. Nilsson R.I., Nordlinder R., Horte L.G., and Jarvholm B. Leukaemia, lymphoma, and multiple myeloma in seamen on tankers. Occup Environ Med 55 (1998) 517-521
29. Sorahan T., Kinlen L.J., and Doll R. Cancer risks in a historical UK cohort of benzene exposed workers. Occup Environ Med 62 (2005) 231-236
30. Glass D.C., Gray C.N., Jolley D.J., Gibbons C., Sim M.R., Fritschi L., et al. Leukemia risk associated with low-level benzene exposure. Epidemiology 14 (2003) 569-577
31. Sonoda T., Nagata Y., Mori M., Ishida T., and Imai K. Meta-analysis of multiple myeloma and benzene exposure. J Epidemiol 11 (2001) 249-254
32. Wong O., Trent L., and Harris F. Nested case-control study of leukaemia, multiple myeloma, and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup Environ Med 56 (1999) 217-221
33. Zhang D.S., Lin G.F., Ma Q.W., and Shen J.H. Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta Pharmacol Sin 23 (2002) 188-192
34. De Roos A.J., Gold L.S., Wang S., Hartge P., Cerhan J.R., Cozen W., et al. Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 15 (2006) 1647-1653
35. Bergamaschi E., Catalani S., Folesani G., Venco P., Bodini E., Guidetti F., et al. [Environmental and biological monitoring of exposure to polycyclic aromatic hydrocarbons in workers of an electric steel foundry]. Med Lav 96 (2005) 390-402
36. Singhi M.K., Menghani P.R., Gupta L.K., Kachhawa D., and Bansal M. Occupational contact dermatitis among the traditional 'tie and dye' cottage industry in western Rajasthan. Indian J Dermatol Venereol Leprol 71 (2005) 329-332
37. Chen B., Hu Y., Jin T., Lu D., Shao M., Zheng L., et al. The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ 381 (2007) 38-46
38. Hosgood III H.D., Baris D., Zahm S.H., Zheng T., and Cross A.J. Diet and risk of multiple myeloma in Connecticut women. Cancer Causes Control 18 10 (2007) 1065-1076
39. Landgren O., Zhang Y., Zahm S.H., Inskip P., Zheng T., and Baris D. Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev 15 (2006) 2342-2347
40. Chatterjee N., Hartge P., Cerhan J.R., Cozen W., Davis S., Ishibe N., et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13 (2004) 1415-1421
41. Engels E.A., Chatterjee N., Cerhan J.R., Davis S., Cozen W., Severson R.K., et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 111 (2004) 76-80
42. Engels E.A., Viscidi R.P., Galloway D.A., Carter J.J., Cerhan JRr, Davis S., et al. Case-control study of Simian Virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 96 (2004) 1368-1374
43. Engels E.A., Cerhan J.R., Linet M.S., Cozen W., Colt J.S., Davis S., et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 162 (2005) 1153-1161
44. Engels E.A., Chen J., Hartge P., Cerhan J.R., Davis S., Severson R.K., et al. Antibody responses to Simian Virus 40 T antigen: a case-control study of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 14 (2005) 521-524
45. Garcia-Closas M., Egan K.M., Abruzzo J., Newcomb P.A., Titus-Ernstoff L., Franklin T., et al. Collection of genomic dna from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 10 (2001) 687-696
46. Packer B.R., Yeager M., Staats B., Welch R., Crenshaw A., Kiley M., et al. SNP500cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 32 (2004) D528-D532
47. Rollison De, Helzlsouer K.J., and Pinney S.M. Personal hair dye use and cancer: a systematic literature review and evaluation of exposure assessment in studies published since 1992. J Toxicol Environ Health B Crit Rev 9 (2006) 413-439
48. Paracchini V., Raimondi S., Gram I.T., Kang D., Kocabas N.A., Kristensen V.N., et al. Meta- and pooled analyses of the cytochrome P-450 1b1 Val432leu polymorphism and breast cancer: a huge-gsec review. Am J Epidemiol 165 (2007) 115-125
49. Van Duursen M.B., Sanderson J.T., and Van Den B.M. Cytochrome P450 1a1 and 1b1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol Sci 85 (2005) 703-712
50. Shimada T., Oda Y., Gillam E.M., Guengerich F.P., and Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1a1 and P450 1b1 allelic variants and other human cytochromes P450 in Salmonella Typhimurium Nm2009. Drug Metab Dispos 29 (2001) 1176-1182
51. Shimada T., Watanabe J., Inoue K., Guengerich F.P., and Gillam E.M. Specificity of 17beta-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501b1 variants substituted at residues 48, 119 and 432. Xenobiotica 31 (2001) 163-176
52. Cussenot O., Azzouzi A.R., Nicolaiew N., Fromont G., Mangin P., Cormier L., et al. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: The Hidden Face of Estrogens. J Clin Oncol 25 (2007) 3596-3602
53. Sillanpaa P., Heikinheimo L., Kataja V., Eskelinen M., Kosma V.M., Uusitupa M., et al. Cyp1a1 and Cyp1b1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Res Treat 104 (2007) 287-297
54. Lincz L.F., Kerridge I., Scorgie F.E., Bailey M., Enno A., and Spencer A. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89 (2004) 628-629
55. Kerridge I., Lincz L., Scorgie F., Hickey D., Granter N., and Spencer A. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 118 (2002) 477-481
56. Lincz L.F., Scorgie F.E., Robertson R., and Enno A. Genetic variations in benzene metabolism and susceptibility to multiple myeloma. Leuk Res 31 6 (2007) 759-763
57. Bhatti P., Sigurdson A.J., Wang S.S., Chen J., Rothman N., Hartge P., et al. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol Biomarkers Prev 14 (2005) 2449-2453
58. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (2004) 434-442